The IKF AI algorithm suggested 4D Molecular Therapeutics, Inc. (FDMT) as one of the most promising stocks in our Biotech stocks package on November 15, 2022.

The stock increased by 38.55% in line with the I Know First AI forecast on November 15, 2022.

Past Success With FDMT Stock Forecast

I Know First has been bulish on the FDMT stock forecast in the past. On November 11^th, 2022 the I Know First algorithm issued a forecast for FDMT stock price and recommended FDMT as one of the best biotech stocks to go buy. The AI-driven FDMT stock prediction was successful on a 3-day time horizon resulting in more than 38.64%

Stock Market Forecast: I Know First’s Machine Learning Algorithm

I Know First is one leading company that has been effectively using machine learning and AI-based algorithms to provide daily forecasts and facilitate trading for over 13,500 financial instruments. More importantly, I Know First’s algorithm does not depend on any human-derived assumptions except for the mathematical framework initially presented, meaning that it is more reliable and accurate than using technical indicators which involve a lot of human judgments. The algorithms can present patterns based on the data inputs, testing the performance on years of market data, and validating them on the most recent data, which prevents overfitting. If an input does not improve the model, it is “rejected”, and another input can be submitted. I Know First provides different forecast packages based on the AI algorithm which allows us to select the most promising stocks (you can access them here).

To subscribe today click here.

Please note-for trading decisions use the most recent forecast.

Short-Term Stock Forecast